PropertyValue
?:abstract
  • We report that the SARS-CoV-2 nucleocapsid protein (N-protein) undergoes liquid-liquid phase separation (LLPS) with viral RNA. N-protein condenses with specific RNA genomic elements under physiological buffer conditions and condensation is enhanced at human body temperatures (33°C and 37°C) and reduced at room temperature (22°C). RNA sequence and structure in specific genomic regions regulate N-protein condensation while other genomic regions promote condensate dissolution, potentially preventing aggregation of the large genome. At low concentrations, N-protein preferentially crosslinks to specific regions with single-stranded RNA flanked by structure and these features specify the location, number, and strength of N-protein binding sites (valency). Liquid-like N-protein condensates form in mammalian cells in a concentration-dependent manner and can be altered by small molecules. Condensation of N-protein is RNA sequence and structure specific, sensitive to human body temperature, and manipulatable with small molecules, and presents a screenable process for identifying antiviral compounds effective against SARS-CoV-2.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.molcel.2020.11.041
?:journal
  • Mol_Cell
?:license
  • els-covid
?:pdf_json_files
  • document_parses/pdf_json/9453acec5be67e8ce8dc5c7add59bcf230d01e96.json
?:pmcid
?:pmid
?:pmid
  • 33290746.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Genomic RNA elements drive phase separation of the SARS-CoV-2 nucleocapsid
?:type
?:year
  • 2020-11-27

Metadata

Anon_0  
expand all